CANCOM SE header image

CANCOM SE

COK

Equity

ISIN DE0005419105 / Valor 883557

Xetra (2024-11-21)
EUR 23.98-0.66%

CANCOM SE
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

CANCOM SE is a leading provider of IT solutions, offering tailor-made services to organizations seeking to navigate the digital landscape. With a workforce of over 5,600 employees and a presence in various countries, including the DACH region, Belgium, Slovakia, Romania, and the Czech Republic, CANCOM supports clients in their digital transformation journey. The company's comprehensive range of IT services aims to streamline operations and enhance efficiency for businesses looking to adapt to the evolving technological landscape.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (07.08.2024):

Revenue Growth

CANCOM SE reported significant revenue growth in the first half of 2023. The company achieved a notable increase in its revenue, reflecting its strong market position and successful business strategies during this period.

Gross Profit Increase

In the first half of 2023, CANCOM SE also saw a substantial rise in gross profit. This growth in profitability highlights the company's effective cost management and operational efficiency.

One-off Effects Impact

During the second quarter of 2023, CANCOM SE experienced one-off effects that burdened its EBITDA and EBITA. Despite these challenges, the company maintained positive revenue and gross profit development.

Full-Year Guidance Adjustment

Due to the one-off effects in the second quarter, the Executive Board of CANCOM SE decided to lower the full-year guidance for 2023. This adjustment reflects a more cautious outlook for the remainder of the year.

First Quarter Performance

In the first quarter of 2023, CANCOM SE reported growth in both revenue and gross profit. This positive performance set a strong foundation for the company's financial results for the rest of the year.

Summarized from source with an LLMView Source

Key figures

-12.6%1Y
-62.0%3Y
-53.3%5Y

Performance

30.3%1Y
37.6%3Y
37.0%5Y

Volatility

Market cap

929 M

Market cap (USD)

Daily traded volume (Shares)

36,029

Daily traded volume (Shares)

1 day high/low

24.2 / 23.82

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Plexus Corp
Plexus Corp Plexus Corp Valor: 963299
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.90%USD 159.63
Oxford Metrics PLC
Oxford Metrics PLC Oxford Metrics PLC Valor: 1222541
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.02%GBP 0.63
Aptamer Group PLC
Aptamer Group PLC Aptamer Group PLC Valor: 115383974
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
10.32%GBP 0.0031
GMO internet group KK
GMO internet group KK GMO internet group KK Valor: 850322
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.66%JPY 2,529.50
Cordel Group PLC
Cordel Group PLC Cordel Group PLC Valor: 41815612
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.63%GBP 0.063
Grifols, SA
Grifols, SA Grifols, SA Valor: 30689493
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.62%EUR 10.40
Santhera Pharmaceuticals Holding Ltd.
Santhera Pharmaceuticals Holding Ltd. Santhera Pharmaceuticals Holding Ltd. Valor: 127602882
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.05%CHF 7.90
Kanzhun Limited
Kanzhun Limited Kanzhun Limited Valor: 111844659
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 6.25
Softing AG
Softing AG Softing AG Valor: 1080222
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.70%EUR 3.60
Vera Therapeutics Inc
Vera Therapeutics Inc Vera Therapeutics Inc Valor: 111319498
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.80%USD 47.03